Prosecution Insights
Last updated: May 29, 2026

Abiomed Europe GmbH

6 pending office actions • 5 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 22 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
5
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
4
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
6
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
6
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WOZNICKI, JACQUELINE 2 49.7% +27.0%
HOFFA, ANGELA MARIE 1 67.3% +27.1%
KOWALKOWSKI, FIONA MARGARET 1
GHAND, JENNIFER LEIGH-STEWAR 1 60.4% +28.3%
RODJOM, KATHERINE MARIE 1 65.8% +33.9%

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
17435256 BLOOD PUMP WOZNICKI, JACQUELINE 111d overdue
17507500 VASCULAR ACCESS RODJOM, KATHERINE MARIE 103d overdue
17793578 INTRAVASCULAR BLOOD PUMP WOZNICKI, JACQUELINE 9d
18846060 SYSTEM FOR TRACKING REAL-TIME POSITIONS OF A MOVABLE SENSOR WITHIN A PATIENT'S BODY HOFFA, ANGELA MARIE 14d
18025761 BLOOD PUMP GHAND, JENNIFER LEIGH-STEWAR 19d

Top Art Units

Art UnitApps
3774 2
3799 1
3792 1
3796 1
3771 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18846060 SYSTEM FOR TRACKING REAL-TIME POSITIONS OF A MOVABLE SENSOR WITHIN A PATIENT'S BODY HOFFA, ANGELA MARIE 3799 §103 Non-Final OA 14d Pending Sep 11, 2024
18717826 PUMP HOUSING FOR A BLOOD PUMP AND BLOOD PUMP KOWALKOWSKI, FIONA MARGARET 3792 §103 Non-Final OA 16d Pending Jun 07, 2024
18025761 BLOOD PUMP GHAND, JENNIFER LEIGH-STEWAR 3796 §103 Non-Final OA 19d Pending Mar 10, 2023
17793578 INTRAVASCULAR BLOOD PUMP WOZNICKI, JACQUELINE 3774 §103 Non-Final OA 9d Pending Jul 18, 2022
17507500 VASCULAR ACCESS RODJOM, KATHERINE MARIE 3771 §103 Non-Final OA 103d overdue Pending Oct 21, 2021
17435256 BLOOD PUMP WOZNICKI, JACQUELINE 3774 §103 Non-Final OA 111d overdue Pending Aug 31, 2021

Managing Abiomed Europe GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month